14 results
8-K
EX-99.1
ONCR
Oncorus, Inc.
10 Jan 22
Regulation FD Disclosure
8:17am
strain (Kuykendall) Targets ICAM expressing tumors Indications Patient Samples Tested (N) ICAM+ Prevalence NSCLC 97 72% HCC 69 72% RCC 67 79% Note … vRNA encoding for the synthetic Seneca Valley Virus (SVV) Targets SCLC & neuroendocrine prostate Induces tumor regression & improves survival
10-K
3i6e125x40
10 Mar 21
Annual report
4:12pm
424B4
5hvhph9
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS
mazmn7
28 Jan 21
Draft registration statement
12:00am
424B4
jpxq5yycdah
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
xmc 48cdnm0e
11 Sep 20
IPO registration
4:49pm
CORRESP
qviq8grrbyr
11 Sep 20
Correspondence with SEC
12:00am
DRS/A
zdsosv91n85v3v
26 Aug 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next